Founded in 1998 by Dr. Stéphane EImer, Biogroup stands as a major medical biology player in Europe. In 2015, EMZ arranged a bond financing to partly finance the acquisition of Laboratoires LCD. EMZ funds have then participated in the financing of the group’s strategic acquisitions on three occasions in France and abroad. In particular, in 2020, EMZ financed the acquisition of CMA-Médina, the leading Belgian player. Since Stéphane EImer’s death on June 22nd 2022, the group is headed by his wife Isabelle Eimer with the support of the management team.
|Routine medical biology